Literature DB >> 20877346

Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed.

David B Wang1, Robert D Dayton, Phillip P Henning, Cooper D Cain, Li Ru Zhao, Lisa M Schrott, Elysse A Orchard, David S Knight, Ronald L Klein.   

Abstract

Improved spread of transduction in the central nervous system (CNS) was achieved from intravenous administration of adeno-associated virus serotype-9 (AAV9) to neonatal rats. Spinal lower motor neuron transduction efficiency was estimated to be 78% using the highest vector dose tested at a 12-week interval. The widespread expression could aid studying diseases that affect both the spinal cord and brain, such as amyotrophic lateral sclerosis (ALS). The protein most relevant to neuropathology in ALS is transactive response DNA-binding protein 43 (TDP-43). When expressed in rats, human wild-type TDP-43 rapidly produced symptoms germane to ALS including paralysis of the hindlimbs and muscle wasting, and mortality over 4 weeks that did not occur in controls. The hindlimb atrophy and weakness was evidenced by assessments of rotarod, rearing, overall locomotion, muscle mass, and histology. The muscle wasting suggested denervation, but there was only 14% loss of motor neurons in the TDP-43 rats. Tissues were negative for ubiquitinated, cytoplasmic TDP-43 pathology, suggesting that altering TDP-43's nuclear function was sufficient to cause the disease state. Other relevant pathology in the rats included microgliosis and degenerating neuronal perikarya positive for phospho-neurofilament. The expression pattern encompassed the distribution of neuropathology of ALS, and could provide a rapid, relevant screening assay for TDP-43 variants and other disease-related proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20877346      PMCID: PMC2997590          DOI: 10.1038/mt.2010.191

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  40 in total

Review 1.  Amyotrophic lateral sclerosis: A 40-year personal perspective.

Authors:  Andrew Eisen
Journal:  J Clin Neurosci       Date:  2009-02-23       Impact factor: 1.961

Review 2.  Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease.

Authors:  Emanuele Buratti; Francisco E Baralle
Journal:  Front Biosci       Date:  2008-01-01

3.  Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.

Authors:  Yong-Jie Zhang; Ya-Fei Xu; Casey Cook; Tania F Gendron; Paul Roettges; Christopher D Link; Wen-Lang Lin; Jimei Tong; Monica Castanedes-Casey; Peter Ash; Jennifer Gass; Vijayaraghavan Rangachari; Emanuele Buratti; Francisco Baralle; Todd E Golde; Dennis W Dickson; Leonard Petrucelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

4.  Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

Authors:  Kevin D Foust; Emily Nurre; Chrystal L Montgomery; Anna Hernandez; Curtis M Chan; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2008-12-21       Impact factor: 54.908

5.  Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior.

Authors:  Fabian Feiguin; Vinay K Godena; Giulia Romano; Andrea D'Ambrogio; Raffaella Klima; Francisco E Baralle
Journal:  FEBS Lett       Date:  2009-04-19       Impact factor: 4.124

6.  Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression.

Authors:  Jason B Tatom; David B Wang; Robert D Dayton; Omar Skalli; Michael L Hutton; Dennis W Dickson; Ronald L Klein
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

7.  Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

Authors:  Hanae Nakashima-Yasuda; Kunihiro Uryu; John Robinson; Sharon X Xie; Howard Hurtig; John E Duda; Steven E Arnold; Andrew Siderowf; Murray Grossman; James B Leverenz; Randy Woltjer; Oscar L Lopez; Ronald Hamilton; Debby W Tsuang; Douglas Galasko; Eliezer Masliah; Jeffrey Kaye; Christopher M Clark; Thomas J Montine; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2007-07-25       Impact factor: 17.088

8.  Pallidonigral TDP-43 pathology in Perry syndrome.

Authors:  Christian Wider; Dennis W Dickson; A Jon Stoessl; Yoshio Tsuboi; Françoise Chapon; Ludwig Gutmann; Bernard Lechevalier; Donald B Calne; David A Personett; Mary Hulihan; Jennifer Kachergus; Rosa Rademakers; Matthew C Baker; Linda L Grantier; O K Sujith; Laura Brown; Susan Calne; Matthew J Farrer; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2008-08-23       Impact factor: 4.891

Review 9.  Molecular neuropathology of TDP-43 proteinopathies.

Authors:  Manuela Neumann
Journal:  Int J Mol Sci       Date:  2009-01-09       Impact factor: 6.208

10.  TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.

Authors:  Jemeen Sreedharan; Ian P Blair; Vineeta B Tripathi; Xun Hu; Caroline Vance; Boris Rogelj; Steven Ackerley; Jennifer C Durnall; Kelly L Williams; Emanuele Buratti; Francisco Baralle; Jacqueline de Belleroche; J Douglas Mitchell; P Nigel Leigh; Ammar Al-Chalabi; Christopher C Miller; Garth Nicholson; Christopher E Shaw
Journal:  Science       Date:  2008-02-28       Impact factor: 47.728

View more
  37 in total

Review 1.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

2.  Efficient central nervous system AAVrh10-mediated intrathecal gene transfer in adult and neonate rats.

Authors:  J Hordeaux; L Dubreil; J Deniaud; F Iacobelli; S Moreau; M Ledevin; C Le Guiner; V Blouin; J Le Duff; A Mendes-Madeira; F Rolling; Y Cherel; P Moullier; M-A Colle
Journal:  Gene Ther       Date:  2015-01-15       Impact factor: 5.250

Review 3.  Gene therapy for neurological disorders: progress and prospects.

Authors:  Benjamin E Deverman; Bernard M Ravina; Krystof S Bankiewicz; Steven M Paul; Dinah W Y Sah
Journal:  Nat Rev Drug Discov       Date:  2018-08-10       Impact factor: 84.694

4.  Initial gene vector dosing for studying symptomatology of amyotrophic lateral sclerosis in non-human primates.

Authors:  Kasey L Jackson; Robert D Dayton; Jeanne M Fisher-Perkins; Peter J Didier; Kate C Baker; Maria Weimer; Amparo Gutierrez; Cooper D Cain; J Michael Mathis; Michael A Gitcho; Bruce A Bunnell; Ronald L Klein
Journal:  J Med Primatol       Date:  2015-01-29       Impact factor: 0.667

5.  In utero delivery of rAAV2/9 induces neuronal expression of the transgene in the brain: towards new models of Parkinson's disease.

Authors:  L Chansel-Debordeaux; M Bourdenx; S Dovero; V Grouthier; N Dutheil; A Espana; L Groc; C Jimenez; E Bezard; B Dehay
Journal:  Gene Ther       Date:  2017-11-16       Impact factor: 5.250

6.  Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction.

Authors:  Mychal S Grames; Kasey L Jackson; Robert D Dayton; John A Stanford; Ronald L Klein
Journal:  J Vis Exp       Date:  2017-08-25       Impact factor: 1.355

Review 7.  TDP-43 autoregulation: implications for disease.

Authors:  Mauricio Budini; Emanuele Buratti
Journal:  J Mol Neurosci       Date:  2011-06-18       Impact factor: 3.444

8.  Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1.

Authors:  Sami J Barmada; Shulin Ju; Arpana Arjun; Anthony Batarse; Hilary C Archbold; Daniel Peisach; Xingli Li; Yuxi Zhang; Elizabeth M H Tank; Haiyan Qiu; Eric J Huang; Dagmar Ringe; Gregory A Petsko; Steven Finkbeiner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

9.  Opposing actions of hippocampus TNFα receptors on limbic seizure susceptibility.

Authors:  Marc S Weinberg; Bonita L Blake; Thomas J McCown
Journal:  Exp Neurol       Date:  2013-01-16       Impact factor: 5.330

10.  Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis.

Authors:  Robert D Dayton; Michael A Gitcho; Elysse A Orchard; Jon D Wilson; David B Wang; Cooper D Cain; Jeffrey A Johnson; Yong-Jie Zhang; Leonard Petrucelli; J Michael Mathis; Ronald L Klein
Journal:  Mol Ther       Date:  2013-05-21       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.